Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Qing Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3602-144X; OpenAlex author ID A5100765961. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 4

  1. Correction: Osthole induces accumulation of impaired autophagosome against pancreatic cancer cells. Co-author DOI 10.1038/s41598-026-42597-7↗
  2. Author Correction: Osthole induces accumulation of impaired autophagosome against pancreatic cancer cells. Co-author DOI 10.1038/s41598-025-97328-1↗
  3. CX26 promotes pancreatic cancer progression by competitively inhibiting interaction of c-Myc with PSMD2 and enhancing c-Myc stability. Co-author DOI 10.1186/s12967-025-06983-5↗
  4. Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1039/d4nr01587h↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ningna Weng · 2 shared papers, 2025–2026 · strength 0.58
  2. S. Huang · 1 shared paper, 2026 · strength 0.32
  3. Chihua Fang · 1 shared paper, 2025 · strength 0.30
  4. Cheng He · 1 shared paper, 2025 · strength 0.30
  5. Sha Huang · 1 shared paper, 2025 · strength 0.27
  6. Chihua Fang · 1 shared paper, 2024 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.